DR. VICENTE D. NARCISO, M.D.

Plain English
This study looked at a 63-year-old man who had chest pain and breathing problems during exercise, despite previously being treated for heart issues without success. The doctors performed a single, detailed test that revealed two conditions: his heart function was preserved but still not working well (HFpEF), and there was a problem with the small blood vessels in his heart (ANOCA/INOCA). By identifying both issues at once, they were able to provide targeted treatment that improved his symptoms. Who this helps: This helps patients experiencing chest pain and breathing difficulties when they don't have blockages in their coronary arteries.

Plain English
This study looked at ways to better manage the health of patients with severe heart disease who have undergone a specific heart procedure called percutaneous coronary intervention. Researchers found that many of these patients still face a high risk of further heart problems, even after treatment, due to factors like high cholesterol, diabetes, and obesity. By focusing on improving metabolic health, such as targeting obesity and diabetes, doctors can significantly reduce these risks and improve patient outcomes. Who this helps: This helps patients with heart disease and their doctors.

Plain English
This research paper looks at acute heart failure (AHF) and its connection to different heart muscle diseases called cardiomyopathies (CMPs). The findings reveal that AHF is a leading cause of hospitalization for people over 65 and has high rates of death and repeated hospital visits, especially in patients with dilated cardiomyopathy, where it is the most frequent cause of death. Understanding AHF better could lead to improved treatment and outcomes for patients. Who this helps: This helps patients with heart conditions, especially those with cardiomyopathies.

Plain English
This research paper examines the treatment options for patients with atrial fibrillation (AF) who are also undergoing a procedure called percutaneous coronary intervention (PCI) to improve blood flow in their heart. It finds that while using dual antithrombotic therapy (DAT) with two medications reduces the risk of bleeding, it can lead to a higher chance of blood clots forming on heart stents. Addressing the balance between preventing strokes and minimizing bleeding is crucial for these patients. Who this helps: This helps patients with atrial fibrillation undergoing heart procedures, as well as their doctors.

Plain English
This study looked at how best to prevent further heart problems in patients who have already undergone a procedure to open blocked arteries, known as percutaneous coronary intervention (PCI). It found that focusing on lowering harmful fats (lipids) and reducing inflammation in the body can significantly lower the risk of new cardiovascular events in these patients. Managing these factors can help address a significant remaining risk that many patients face even after receiving standard treatments. Who this helps: This benefits patients who have had heart procedures and are at risk of further complications.

Plain English
This study looked at neuroendocrine neoplasms (NENs), which are rare tumors that produce hormones and are difficult to diagnose. Researchers used a variety of techniques to analyze different aspects of the tumors and found important signals and genetic features that could help identify and treat these cancers better. They discovered that a specific signaling pathway is involved in many of these tumors and identified certain microRNAs that might serve as useful biomarkers for diagnosis and treatment. Who this helps: This research benefits patients with neuroendocrine tumors and their doctors by improving diagnosis and treatment options.

Plain English
This study looked at whether getting rid of the hepatitis C virus (HCV) using direct-acting antiviral treatments (DAAs) lowers the risk of serious heart problems and strokes. The research involved 2,204 patients with HCV and found that those who were successfully treated had a significantly lower rate of cardiovascular events—0.44 per 100 patient years compared to 1.14 in untreated patients. This is important because it shows that clearing HCV can greatly reduce heart disease risk, with the benefit seen for roughly every 55 people treated. Who this helps: This helps patients with hepatitis C and healthcare providers who treat them.

Plain English
This study looked at how clearing the hepatitis C virus (HCV) affects the chances of developing type 2 diabetes in patients. Researchers followed 2,426 patients, with those treated for HCV showing a significant drop in diabetes cases – only 7 out of 1,000 developed diabetes compared to 28 out of 1,000 in untreated patients. This matters because treating HCV not only clears the virus but also greatly reduces the risk of diabetes, with an estimated one diabetes case prevented for every 15 patients treated. Who this helps: This benefits patients with chronic hepatitis C by potentially lowering their risk of developing type 2 diabetes.

Plain English
This study looked at a grape-derived supplement called Taurisolo to see if it could lower levels of a substance called TMAO, which is linked to heart disease. After 4 weeks, people taking Taurisolo saw TMAO levels drop by about 64%, while those on a placebo showed almost no change. This finding is important because reducing TMAO may help prevent heart problems in the future. Who this helps: Patients at risk for cardiovascular diseases.

Plain English
This study looked at how grape pomace extract, with or without added pectin, affects levels of a compound called TMAO in the blood of overweight or obese people. After eight weeks, both groups experienced a significant drop in TMAO levels—by about 78.6% in the grape extract group and 76.8% in the grape extract plus pectin group. This reduction is important because high TMAO levels are linked to greater risks of heart disease, suggesting that this grape-based supplement could help lower cardiovascular risk. Who this helps: Patients with overweight or obesity looking to improve their heart health.

Plain English
This research paper looks at how resveratrol, a plant compound found in foods like grapes, may help fight the herpes simplex virus (HSV), which can cause painful sores and, in some cases, serious health issues. The review found that resveratrol shows strong ability to combat HSV through various mechanisms, making it a promising option amidst concerns about drug-resistant strains of the virus. This matters because finding new treatments for HSV is essential for improving patient care, especially for those who have recurring infections. Who this helps: This helps patients struggling with herpes infections.

Plain English
This study looked at how special tiny emulsions loaded with anti-inflammatory nutrients, like curcumin and lycopene from tomatoes, can protect heart cells from damage caused by the cancer drug doxorubicin. The researchers found that heart cells treated with these emulsions experienced a 35-40% higher survival rate compared to those that received just the drug, and also showed reduced inflammation and oxidative stress. These findings are important because they suggest a way to protect patients’ hearts while using a powerful cancer treatment. Who this helps: This helps cancer patients who are at risk of heart damage from doxorubicin.

Plain English
This study looked at how well different types of tea (white, green, and black) release beneficial compounds called polyphenols during digestion and how effective these compounds are at fighting free radicals, which can cause damage in the body. The researchers found that after digestion, the amount of tea polyphenols available for absorption in the colon was much higher than in earlier stages of digestion, with antioxidant activity significantly increasing in the colon. This is important because it shows that even if polyphenols aren’t absorbed well in the upper digestive tract, they can still provide health benefits in the lower gut, potentially helping with inflammatory conditions. Who this helps: Patients with gut-related inflammatory diseases.

Plain English
This study analyzed how well two medications, boceprevir and telaprevir, work together with other treatments for patients with hepatitis C genotype 1 in Italy. Researchers looked at data from 834 patients across multiple centers and found that 62.7% of the patients treated achieved good results, but only 43.8% of older patients with liver damage did. The results show that while this combination of therapies is generally safe, it may not be very effective for older patients with serious liver problems. Who this helps: This research is beneficial for patients with hepatitis C, particularly older individuals and those with advanced liver disease.

Plain English
This study looked at the effectiveness of combining two medications, desmopressin and oxybutynin, to treat a specific type of nighttime bedwetting in children, known as monosymptomatic nocturnal enuresis. Out of 206 children ages 6 to 13, those taking the combination treatment had a success rate of 45% in reducing bedwetting, compared to just 17% for those on a placebo. The study also found that children who responded well to treatment had lower bladder capacity and thicker bladder walls, which could help in deciding the best treatment approach for individual patients. Who this helps: This research benefits children with nighttime bedwetting and their doctors by providing insights into more effective treatment options.

Plain English
This study looked at the connection between bedwetting in children (called enuresis) and nighttime urination in their mothers (called nocturia). Out of 250 mothers studied, 38% reported having nocturia, and a significant 65% of those mothers had experienced bedwetting as children. The findings indicate that mothers who dealt with enuresis as kids are more likely to have children who also experience bedwetting, raising concerns about family patterns of these issues. Who this helps: This helps families experiencing bedwetting and healthcare providers addressing these issues.

Plain English
This study looked at how burnout affects feelings of hopelessness and the risk of suicide among 133 medical doctors. The findings showed that doctors experiencing high burnout reported feeling much more hopeless, with higher scores indicating greater disengagement and exhaustion. Specifically, those with high hopelessness had burnout scores of 2.61 for disengagement and 2.68 for exhaustion, compared to 2.14 and 2.19 for those with low hopelessness. This matters because understanding this relationship can lead to better support and interventions for doctors, ultimately improving their mental health and patient care. Who this helps: This helps medical doctors and healthcare organizations supporting their well-being.

Plain English
This study looked at 150 psychiatric patients to understand how their personalities and temperaments relate to suicidal behavior. It found that patients at risk for suicide tend to be more socially withdrawn and anxious, while a more upbeat personality can protect against hopelessness. The study highlighted that features like irritability and feelings of hopelessness are strong indicators of suicide risk, which is crucial for improving mental health care and intervention strategies. Who this helps: This helps patients at risk for suicide and their mental health care providers.

Plain English
This study looked at 312 Italian university students to understand how their feelings of hopelessness affected their willingness to take risks and their reasons for wanting to live. It found that students who felt more hopeless and had fewer reasons to live were more likely to take risks and rated those risks as less scary. Specifically, women tended to feel less hopeless and had more reasons for living compared to men, who generally felt more hopeless and engaged in riskier behavior. Who this helps: This research helps universities and mental health professionals understand the link between students' mental health and risk-taking behavior.